瘤突变负担预测不同癌症类型的微卫星稳定瘤中的新抗原概况和免疫治疗反应
Olesia Kondrateva1,2,3, Tugce Bilgin Sonay1,2, Inti Zlobec4
1Institute of Computational Life Sciences, School of Life Sciences and Facility Management, Zürich University of Applied Sciences (ZHAW), Waedenswil, Switzerland.
Frontiers in immunology
|January 26, 2026
概括
瘤突变负担 (TMB) 可以识别受益于免疫治疗的微卫星稳定 (MSS) 瘤. 在MSS瘤中高的TMB与POLE突变和类似于MSI-H瘤的免疫特征有关,这表明免疫治疗反应得到改善.
科学领域:
- 在瘤学瘤学.
- 癌症基因组学 癌症基因组学
- 免疫治疗是一种免疫疗法.
背景情况:
- 免疫疗法对微卫星不稳定高 (MSI-H) 瘤有效.
- 在微卫星稳定 (MSS) 瘤中有效性有限.
- 瘤突变负担 (TMB) 可以确定可以从免疫治疗中受益的MSS瘤的一个子集.
研究的目的:
- 调查TMB是否可以识别受益于免疫治疗的MSS瘤.
- 分析高TMB MSS瘤的分子特征.
- 探索TMB作为MSS瘤中免疫治疗反应的预测生物标志物.
主要方法:
- 从结直肠癌数据集 (TCGA-COAD,TCGA-READ) 中分析分子数据.
- 评估突变格局,特征,免疫细胞概况和不同TMB的MSS瘤中的新抗原负载.
- 将发现扩展到MSI分类的其他癌症类型.
主要成果:
- 具有TMB>50个突变/兆基的MSS瘤表现出POLE基因突变,导致高突变.
- 这些超突变的MSS瘤显示出类似于MSI-H瘤的免疫细胞特征.
- 与低TMB MSS瘤相比,高TMB MSS瘤具有显著更多的新抗原,包括高亲和度的新抗原.
结论:
- TMB是预测MSS瘤中新抗原负载的相关生物标志物.
- 在MSS瘤中高的TMB与免疫治疗相关的特征有关.
- TMB可能有助于选择可以从免疫治疗中受益的MSS患者.
相关概念视频
Tumor Immunotherapy
1.9K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.9K
Cancer Stem Cells and Tumor Maintenance
6.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.0K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.8K
Mutations
94.4K
Overview
94.4K
Tumor Progression
7.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
The Tumor Microenvironment
7.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.8K


